93 related articles for article (PubMed ID: 2873619)
1. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
[No Abstract] [Full Text] [Related]
2. Fluperlapine vs haloperidol: a comparison of their neuroendocrinological profiles and the influence on serum lipids.
Fleischhacker WW; Stuppäck C; Moser C; Schubert H; Hinterhuber H
Pharmacopsychiatry; 1986 May; 19(3):111-4. PubMed ID: 2873601
[TBL] [Abstract][Full Text] [Related]
3. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
4. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
[TBL] [Abstract][Full Text] [Related]
5. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
Cassano GB; Castrogiovanni P; Conti L; Bonollo L
Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
7. [Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
Yang WJ
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):277-80, 318-9. PubMed ID: 3069383
[No Abstract] [Full Text] [Related]
8. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
[TBL] [Abstract][Full Text] [Related]
9. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic effects of verapamil in schizophrenia.
Price WA
Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
12. Clozapine: double-blind control trial in the treatment of acute schizophrenia [proceedings].
Shopsin B; Klein H; Aronson M
Psychopharmacol Bull; 1978 Apr; 14(2):12-5. PubMed ID: 349596
[No Abstract] [Full Text] [Related]
13. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
14. Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.
Bechelli LP; Navas-Filho F
Encephale; 1986; 12(3):121-5. PubMed ID: 2876879
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
16. Amoxapine as an antipsychotic: comparative study versus haloperidol.
Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
[TBL] [Abstract][Full Text] [Related]
17. [Double-blind clinical study of HF 1854 (LX 100-129, clozapine or leponex) as compared with haloperidol].
Ciurezu T; Ionescu R; Nica Udangiu S; Niţurad D; Oproiu L; Tudorache D; Popovici I; Curelaru S
Neurol Psychiatr (Bucur); 1976; 14(1):29-34. PubMed ID: 788132
[No Abstract] [Full Text] [Related]
18. [Introductory words to the exchange of results on the clinical effects of bromperidol. Results of open and double blind research].
Bures E; Pöldinger W
Int Pharmacopsychiatry; 1978; 13 Suppl 1():45-52. PubMed ID: 35479
[No Abstract] [Full Text] [Related]
19. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
Awad AG; Lapierre YD; Angus C; Rylander A
J Psychiatry Neurosci; 1997 Jul; 22(4):244-8. PubMed ID: 9262046
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the clinical effects of bromperidol, a new butyrophenone derivative, and haloperidol on schizophrenia using a double-blind technique.
Itoh H
Psychopharmacol Bull; 1985; 21(1):120-2. PubMed ID: 3885289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
